FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "RequestGroup",
  "id": "mii-exa-onko-molecular-cdk46-protocol",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-therapieempfehlung-kombinationstherapie|2027.0.0-ballot.1"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "status": "active",
  "intent": "proposal",
  "code": {
    "coding": [
      {
        "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
        "code": "CZ"
      }
    ],
    "text": "CDK4/6 Inhibitor + Hormontherapie Kombination"
  },
  "subject": {
    "reference": "Patient/mii-exa-onko-molecular-board-patient"
  },
  "authoredOn": "2024-01-15",
  "reasonReference": [
    {
      "reference": "Condition/primaertumor-example"
    }
  ],
  "action": [
    {
      "title": "CDK4/6 Inhibitor (pharmazeutische Klasse)",
      "description": "Beliebiger CDK4/6 Inhibitor: Palbociclib, Ribociclib oder Abemaciclib je nach Verfügbarkeit und Patientenfaktoren",
      "resource": {
        "reference": "MedicationRequest/mii-exa-onko-cdk46-class-medication"
      }
    }
  ]
}